Drugs Medical Pharma

Glenmark’s drug to treat nausea, psychosis gets FDA nod

India's Glenmark Pharmaceuticals has got the final approval by the USFDA for its generic prochlorperazine maleate tablets, the generic version of compazine of.

Read More
Drugs Health Medical Pharma

FDA panel votes for full approval of Pfizer’s covid pill Paxlovid

The FDA’s advisory panel recommended full approval of Pfizer’s Covid antiviral treatment Paxlovid for high-risk adults.

Read More
Drugs Health Medical Pharma

New report opens a can of worms on COVID-19 origins, WHO steps in

The WHO slammed the Chinese authorities for not being transparent in sharing data related to COVID-19 origins and urged Beijing to conduct "investigations.

Read More
Drugs Medical Pharma

Jubilant HollisterStier gets $17.7 million Canadian funding

Jubilant HollisterStier, a subsidiary of India's Jubilant Pharmova, has got Canada's nod for a partially repayable loan of CAD 23.8 million ($17.7 million).

Read More
Drugs Medical Pharma

Sanofi lowers Lantus insulin costs by 78% in U.S. market

Sanofi, a French pharmaceutical major, announced it would slash the price of insulin, Lantus, by 78% for all U.S. patients with commercial insurance.

Read More
Drugs Medical Pharma

Glenmark gets FDA nod for trials in US on tumour, cancer patients

Glenmark Specialty SA, a subsidiary of India’s Glenmark Pharmaceuticals, has got investigational new drug clearance from the FDA to conduct clinical trials in.

Read More
Medical Pharma

Mediar bags $105 mn from big pharmas to pursue fibrosis treatments

Mediar Therapeutics gets $105 million financing from Novartis, Pfizer, Eli Lilly and Bristol Myers to advance portfolio of first-in-class fibrosis therapies.

Read More
Health Medical Pharma

Fifty-five nations facing a shortage of health workers: WHO

he WHO has identified 55 nations vulnerable to a shortfall in health workers needed to fulfil the UN’s charter for universal health coverage.

Read More
Drugs Medical Pharma

FDA nod for Pfizer-Biotech vaccine booster for children

The FDA cleared the emergency use of bivalent Pfizer-Biotech COVID-19 vaccine for a single dose booster in children aged six months to four.

Read More
Drugs Medical Pharma

Sanofi acquires Provention Bio for $2.9 billion to boost its diabetes portfolio

Sanofi acquires Provention Bio, and its TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes (T1D).

Read More